fda tirzepatide news says compounding pharmacies can keep making weight-loss med tirzepatide, for now FDA NEWS RELEASE: FDA Proposes

Alongside, Vitamin C's antioxidant properties support brain health, which may lower the risk of dementia

10 , e392 (2021)

Discussion In this exploratory analysis using Phase 2 data from studies of participants with T2D or overweight/obesity without T2D, orforglipron treatment was associated with improvement in a number of traditional and novel markers of cardiovascular risk

doi: 10.2217/17460913.1.1.103

"In our future work, we will examine the comparative effectiveness of alternative treatment options for obesity in patients who discontinue semaglutide or tirzepatide, to help patients and their clinicians make informed decisions," lead author Hamlet Gasoyan said

Consultation with a healthcare expert is essential for protection and effectiveness